BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Coapt Systems, Inc. Launches FDA Cleared Novielle Voice (TM) for Restoration of Voice Loss Milestone Marks Company's Entrance into the Injectable Filler Market


9/22/2008 8:04:34 AM

PALO ALTO, Calif., Sept. 21 /PRNewswire/ -- Coapt Systems Inc. today announced the launch of its Novielle Voice family of injectable fillers at the 112th annual meeting of the American Academy of Otolaryngology -- Head and Neck Surgery (AAO-HNS) in Chicago, IL, September 21-24, 2008.

The U.S. Food and Drug Administration (FDA) cleared Novielle Voice Gel and Novielle Voice GelPlus earlier this year for restoration of voice loss. Novielle Voice is available in two formulations based on a proprietary, bioabsorbable Acrylomer(TM) Complex. Novielle Voice is injected into the vocal folds to repair defects that cause the voice to become faint and speaking to become difficult.

According to Dr. David Apfelberg, Medical Director for Coapt Systems, "Examples of patients who can be helped by Novielle Voice injections are patients who have experienced damage to nerves in the voice box, stroke, or surgery of the esophagus. We believe many other patient populations, such as those with Parkinson's disease or presbyphonia, age related loss of voice, can be helped with this simple procedure that can be performed under local anesthesia."

Dr. Edward Damrose is conducting a study on the longevity of Novielle Voice in Northern California, and is enthused. "Novielle Voice is a valuable addition to our armamentarium. I am impressed with our preliminary results and I trust that Novielle will prove useful in addressing the longer term needs of our patients."

"This is the first product line of a complete family of medical and aesthetic Novielle filler products that we plan to introduce. Novielle Voice works by replacing the lost volume in one or both of the vocal folds to restore voice volume and quality and reduce voice effort," said David Barella, Senior Vice President, Global Sales and Marketing. Barella added, "While this is not a permanent solution to voice loss, Novielle Voice will enable us to address the needs of patients who could benefit from intermediate duration injectable products."

Novielle Voice is available in the United States. To learn more, please visit http://www.NovielleVoice.com.

About Coapt Systems

Coapt Systems Inc. designs, develops and markets innovative facial rejuvenation products designed to provide natural, youthful results and reduce recovery time. The Company is privately-held and headquartered in Palo Alto, California. For information on Coapt Systems, please visit http://www.coaptsystems.com.

CONTACT: Charlotte Copeland, Global Marketing Director, Voice and Dermal
Fillers of Coapt Systems Inc., +1-650-461-7676, ccopeland@coaptsystems.com

Web site: http://www.coaptsystems.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES